Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data.

Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data.

Infliximab (IFX) therapy has considerably improved the treatment of rheumatoid arthritis (RA). However, some patients still do not respond adequately to IFX therapy, or the efficacy of the treatment diminishes over time. Although previous studies have reported a relationship between serum IFX levels...

Full description

Bibliographic Details
Main Authors:	Kazuto Nakae, Sho Masui, Atsushi Yonezawa, Motomu Hashimoto, Ryu Watanabe, Koichi Murata, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Kotoko Yokoyama, Noriko Iwamoto, Takashi Shimada, Miyuki Nakamura, Masaya Denda, Kotaro Itohara, Shunsaku Nakagawa, Yasuaki Ikemi, Satoshi Imai, Takayuki Nakagawa, Makoto Hayakari, Kazuo Matsubara
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0258601

Similar Items

Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort
by: Koichi Murata, et al.
Published: (2020-11-01)

Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort
by: Ryu Watanabe, et al.
Published: (2023-04-01)

Predictive value of baseline concomitant glucocorticoid for abatacept-mediated long-term inhibition of radiographic progression: insights from the KURAMA cohort
by: Kosaku Murakami, et al.
Published: (2024-01-01)

Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database.
by: Hiroto Minamino, et al.
Published: (2020-01-01)

Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats.
by: Yuki Otani, et al.
Published: (2017-01-01)

Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort
by: Takayuki Fujii, et al.
Published: (2024-01-01)

Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database
by: Hiroto Minamino, et al.
Published: (2021-01-01)

Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report
by: Sho Masui, et al.
Published: (2019-05-01)

Three groups in the 28 joints for rheumatoid arthritis synovitis--analysis using more than 17,000 assessments in the KURAMA database.
by: Chikashi Terao, et al.
Published: (2013-01-01)

A Minimal Physiologically‐Based Pharmacokinetic Model for Tacrolimus in Living‐Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype
by: Kotaro Itohara, et al.
Published: (2019-08-01)

Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis.
by: Shunsaku Nakagawa, et al.
Published: (2018-01-01)

MicroRNA-101 Regulates 6-Hydroxydopamine-Induced Cell Death by Targeting Suppressor/Enhancer Lin-12-Like in SH-SY5Y Cells
by: Tomohiro Omura, et al.
Published: (2021-12-01)

Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics
by: Kotaro Itohara, et al.
Published: (2022-11-01)

Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study
by: Keiko Ikuta, et al.
Published: (2022-11-01)

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation
by: Yoshiki Katada, et al.
Published: (2022-10-01)

Prevalence of and risk factors for adverse events in Alzheimer's patients receiving anti-dementia drugs in at-home care.
by: Hirohisa Imai, et al.
Published: (2020-01-01)

Yeni Piagetçi Kurama Göre Bilişim Teknolojileri Öğretmen Adaylarının Soyutlama Düzeylerinin ve Programlama Davranışlarının Belirlenmesi
by: Hüseyin Özçınar
Published: (2018-03-01)

Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice
by: Takashi Ogihara, et al.
Published: (2019-12-01)

Metallogenic Specialization Of Sienitoid Small Intrusions And Dikes Of The Kumbel-Ugam Zone Of Depth Faults (Chatkal-Kurama Region, Middle Tian Shan)
by: Mamarozikov U.D., et al.
Published: (2020-12-01)

Infliximab
by: İlgen Ertam Sağduyu
Published: (2022-04-01)

Switch from Infliximab to Infliximab-dyyb for Rheumatology Indications
by: Alexi Spoto, et al.
Published: (2021-05-01)

Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
by: Satoshi Imai, et al.
Published: (2017-07-01)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
by: Reem Kashlan, MPH, et al.
Published: (2021-02-01)

The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors
by: Kotaro Sakamoto, et al.
Published: (2022-05-01)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
by: Fitzgerald T, et al.
Published: (2021-01-01)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019-07-01)

Uso de infliximabe na policondrite recidivante Infliximab in relapsing polychondritis
by: Ana Paula Soares de Barros, et al.
Published: (2010-04-01)

Hidradenite supurativa tratada com infliximabe Hidradenitis suppurativa treated with infliximab
by: Daniel Lago Obadia, et al.
Published: (2009-12-01)

Pharmacist-physician collaborative care for outpatients with left ventricular assist devices using a cloud-based home medical management information-sharing system: a case report
by: Yoshiki Katada, et al.
Published: (2021-02-01)

B-Type Natriuretic Peptide (BNP) Revisited—Is BNP Still a Biomarker for Heart Failure in the Angiotensin Receptor/Neprilysin Inhibitor Era?
by: Toshio Nishikimi, et al.
Published: (2022-07-01)

CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System
by: Yasuaki Nakagawa, et al.
Published: (2022-06-01)

Infliximab for ulcerative colitis.
by: Simmons, J, et al.
Published: (2002)

Infliximab in Crohn's disease
by: L. Rodrigo Sáez

Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort.
by: Yuki Ishikawa, et al.
Published: (2016-01-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01)

Tratamento de hidradenite supurativa com infliximab Treatment of hidradenitis suppurativa with infliximab
by: Tiago Torres, et al.
Published: (2010-08-01)

Control of articular synovitis for bone and cartilage regeneration in rheumatoid arthritis
by: Hiromu Ito, et al.
Published: (2018-04-01)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
by: Dario Sorrentino, et al.
Published: (2015-01-01)

Early infliximab antibody testing does not prevent infusion reactions when reinitiating infliximab
by: Joseph D. Feuerstein
Published: (2016-08-01)

Infliximab no tratamento da artrite psoriásica grave Infliximab in treatment of severe psoriatic arthritis
by: Adriano Jaime Consorte Loyola, et al.
Published: (2005-10-01)